Everolimus Post Pazopanib Treatment in Metastatic or Advanced Renal Cell Carcinoma

NCT01545817 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
74
Enrollment
INDUSTRY
Sponsor class

Stopped As the therapeutic landscape in renal cell carcinoma is changing, it has become apparent that information gained so far by CATChEz study is sufficient.

Conditions

Interventions

Sponsor

Novartis Pharmaceuticals